Cite
MLA Citation
Clive Mason et al.. “1052. Characterisation of the DNA binding properties of ridinilazole, a selective antibiotic currently in phase III trials for the treatment of Clostridioides difficile.” Open forum infectious diseases, vol. 8, n.d., p. S617. http://access.bl.uk/ark:/81055/vdc_100150543656.0x00000b